Quantum Computing Inc. and INmune Bio Partner to Evaluate Drug Repurposing via Quantum Optimization
Quantum Computing Inc. has signed its first commercial biotechnology deal, partnering with INmune Bio to analyze clinical and preclinical data for experimental Alzheimer's drug XPro using quantum optimization.



